Tandem Diabetes Care Announces Launch of t:lock Connector for its Insulin Pump Cartridges and Infusion Sets
The t:lock Connector was designed to look and feel like the previous Luer-lock connector, while improving the customer experience of filling an infusion set with insulin. The Connector incorporates a smaller inner cavity, which reduces the amount of insulin used in the process and reduces the time required to fill the infusion set tubing.
"This launch strengthens our overall insulin delivery systems,
addressing one of our customers' most frequent requests to make the
infusion set fill process more efficient," said
"We are excited to further our current partnership with
Unomedical manufactures Tandem's existing sets as well as many of the
most popular private-labeled infusion sets of major insulin pump
manufacturers under their respective brand names. The t:lock versions of
Tandem's current infusion sets will be sold under the brand names
AutoSoft™, VariSoft™ and TruSteel™. Tandem will conduct a gradual
rollout of its t:lock Connector to all customers and distributors
Information for Current Tandem Customers
No action is required by Tandem customers at this time. Tandem and its authorized distributors will work with customers to provide current Luer-lock versions of infusion sets and cartridges that are compatible with supplies they have on hand before transitioning to the t:lock Connector cartridges and infusion sets (while supplies last). Only t:lock Connector infusion sets will work with the new t:lock Connector cartridges. Infusion sets and cartridges featuring the t:lock Connector will have the same insurance coverage as current supplies.
For more information on the t:lock Connector, please visit www.tandemdiabetes.com/tlock.
t:slim, t:flex, and
Forward Looking Statement
This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that concern matters that involve risks and uncertainties that could cause actual results to differ materially from those anticipated or projected in the forward-looking statements. These forward-looking statements include statements regarding the timing of the rollout of the t:lock Connector and the Company's expectations that the t:lock Connector will make the infusion set fill process more efficient. The Company's actual results may differ materially from those indicated in these forward-looking statements due to numerous risks and uncertainties. For instance, the Company may be unable to manufacture infusion sets with the t:lock connector at volumes necessary to support the needs of its existing and future customers, the anticipated rollout period may take longer than anticipated, and the Company may not ultimately be able to gain market acceptance for the t:lock Connector. In addition, the Company's results may be impacted by the other risks identified in the Company's most recent Annual Report on Form 10-K, Quarterly Report on Form 10-Q, and other documents that the Company files with the
News Provided by Acquire Media